Free Trial
NASDAQ:NVOS

Novo Integrated Sciences (NVOS) Stock Price, News & Analysis

$0.22
-0.01 (-4.36%)
(As of 10/23/2024 ET)

About Novo Integrated Sciences Stock (NASDAQ:NVOS)

Key Stats

Today's Range
$0.21
$0.23
50-Day Range
$0.22
$0.52
52-Week Range
$0.20
$3.45
Volume
958,432 shs
Average Volume
2.61 million shs
Market Capitalization
$4.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology services, such as telemedicine and remote patient monitoring; develops and distributes personalized health and wellness product solutions; and operates corporate-owned clinics. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.

Novo Integrated Sciences Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
24th Percentile Overall Score

NVOS MarketRank™: 

Novo Integrated Sciences scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Percentage of Shares Shorted

    3.87% of the float of Novo Integrated Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Novo Integrated Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novo Integrated Sciences has recently decreased by 14.65%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Novo Integrated Sciences does not currently pay a dividend.

  • Dividend Growth

    Novo Integrated Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.87% of the float of Novo Integrated Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Novo Integrated Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novo Integrated Sciences has recently decreased by 14.65%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Novo Integrated Sciences has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, Novo Integrated Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.90% of the stock of Novo Integrated Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.67% of the stock of Novo Integrated Sciences is held by institutions.

  • Read more about Novo Integrated Sciences' insider trading history.
Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

NVOS Stock News Headlines

Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
See More Headlines

NVOS Stock Analysis - Frequently Asked Questions

Novo Integrated Sciences' stock was trading at $0.8210 at the beginning of the year. Since then, NVOS stock has decreased by 73.3% and is now trading at $0.2195.
View the best growth stocks for 2024 here
.

Shares of Novo Integrated Sciences reverse split on the morning of Tuesday, November 7th 2023. The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Integrated Sciences investors own include AMC Entertainment (AMC), Sangamo Therapeutics (SGMO), Digital World Acquisition (DWAC), NIO (NIO), Biora Therapeutics (BIOR), Brigham Minerals (MNRL) and Tesla (TSLA).

Company Calendar

Today
10/24/2024
Next Earnings (Estimated)
12/12/2024
Fiscal Year End
8/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Engines & turbines
Sub-Industry
Machinery
Current Symbol
NASDAQ:NVOS
Fax
N/A
Employees
127
Year Founded
N/A

Profitability

Net Income
$-13,220,000.00
Net Margins
-179.95%
Pretax Margin
-180.11%

Debt

Sales & Book Value

Annual Sales
$12.57 million
Book Value
$1.64 per share

Miscellaneous

Free Float
16,978,000
Market Cap
$4.18 million
Optionable
Not Optionable
Beta
-1.68
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:NVOS) was last updated on 10/24/2024 by MarketBeat.com Staff
From Our Partners